These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent. Boudanova E; Navaroli DM; Melikian HE Neuropharmacology; 2008 Mar; 54(3):605-12. PubMed ID: 18164041 [TBL] [Abstract][Full Text] [Related]
11. Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization. Jayanthi LD; Samuvel DJ; Ramamoorthy S J Biol Chem; 2004 Apr; 279(18):19315-26. PubMed ID: 14976208 [TBL] [Abstract][Full Text] [Related]
12. Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors. Mannangatti P; Ragu Varman D; Ramamoorthy S; Jayanthi LD Pharmacology; 2021; 106(11-12):597-605. PubMed ID: 34515205 [TBL] [Abstract][Full Text] [Related]
13. Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters. Guptaroy B; Fraser R; Desai A; Zhang M; Gnegy ME Mol Pharmacol; 2011 Mar; 79(3):520-32. PubMed ID: 21149640 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the human norepinephrine transporter in intact 293-hNET cells exposed to desipramine. Zhu MY; Blakely RD; Apparsundaram S; Ordway GA J Neurochem; 1998 Apr; 70(4):1547-55. PubMed ID: 9523572 [TBL] [Abstract][Full Text] [Related]
15. Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles. Mandela P; Chandley M; Xu YY; Zhu MY; Ordway GA Neurochem Int; 2010; 56(6-7):760-7. PubMed ID: 20176067 [TBL] [Abstract][Full Text] [Related]
16. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine. Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986 [TBL] [Abstract][Full Text] [Related]
17. Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism. Park YH; Kantor L; Guptaroy B; Zhang M; Wang KK; Gnegy ME J Neurochem; 2003 Dec; 87(6):1546-57. PubMed ID: 14713310 [TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism. Wei Y; Williams JM; Dipace C; Sung U; Javitch JA; Galli A; Saunders C Mol Pharmacol; 2007 Mar; 71(3):835-42. PubMed ID: 17164407 [TBL] [Abstract][Full Text] [Related]
19. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. Kahlig KM; Javitch JA; Galli A J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of CaMKII in the nucleus accumbens shell decreases enhanced amphetamine intake in sensitized rats. Loweth JA; Baker LK; Guptaa T; Guillory AM; Vezina P Neurosci Lett; 2008 Oct; 444(2):157-60. PubMed ID: 18694805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]